Earnings Watch, Coinbase IPO, Microsoft acquisition, and Alibaba fine

Equities 10 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  It is a busy week ahead for equities with the Q1 earnings season starting on Wednesday with important earnings from Wells Fargo, JPMorgan Chase, and Teladoc Health. Coinbase, the largest cryptocurrency exchange, is also on going public on Wednesday through a direct listing at a rumoured valuation of $100bn which is hefty relative to other exchanges in more traditional financial instruments. Microsoft is rumoured to buy Nuance Communications in a push into health care services and acquiring key speech recognition technology. Finally, we touch on the Alibaba antirust fine of $2.8bn.


Today’s equity update will cover many different topics, but we start with the most important one being the Q1 earnings season starting this week on Wednesday with Wells Fargo and JPMorgan Chase reporting. These two US banks have an enormous footprint in both commercial and consumer banking and will thus provide great insights into the US economic rebound and credit quality. We expect financials to be the big positive surprise during the Q1 earnings season driven by stronger investment banking fees and improving fundamentals in the banking business driven by loan-loss reserves being reduced.

Teladoc Health which is part of our bubble stocks basket is also reporting on Wednesday and will be a key test of sentiment in richly valued stocks. The company grew revenue by 145% y/y in Q4 but at the expense of cash from operations going deeply negative. Analysts are expecting revenue growth of 150% y/y in Q1 with revenue reaching $2bn in 2021.

The overall key theme in Q1 will be whether technology companies will continue to outperform the rest of the market in terms of earnings growth or the positive impulse during the pandemic is finally slowing off, and potentially more rapidly than expected. As the chart below shows, Nasdaq 100 earnings are up 17.5% since Q4 2019 with MSCI World up 3.3% and S&P 500 down 5.8%.

The most important earnings this week:

  • Tuesday: Fastenal
  • Wednesday: Wells Fargo, Teladoc Health, Tesco, JPMorgan Chase, Goldman Sachs, First Republic Bank
  • Thursday: Charles Schwab, Progressive, PepsiCo, Bank of America, Citigroup, PPG Industries, UnitedHealth, BlackRock, US Bancorp, Truist Financial, Delta Air Lines
  • Friday: Tractor Supply

Coinbase IPO and the sustainability of fees

Probably one of the most anticipated IPOs within the crypto industry ever is due on Wednesday with Coinbase, the largest exchange on cryptocurrencies, going public through a direct listing on the Nasdaq exchange under the Saxo ticker code COIN:xnas. The crypto exchange recently announced Q1 net revenue figures of close to $1.8bn which is almost twice the 2020 revenue of Euronext which is one of the largest exchanges in the world in traditional financial instruments. This is really the story of massive increase in adoption of cryptocurrency trading over the past year with Coinbase active userbase hitting 56mn, but it is also a story of elevated transaction fees compared to traditional financial instruments.

It is our expectations that Coinbase will experience fee compression over time as competition heats up. Financial performance for 2021 comes with great uncertainty and the rumoured $100bn valuation of Coinbase seems quite aggressive given that the Intercontinental Exchange is valued at $66bn, so we think all investors should be patient with Coinbase and let the company report a couple of quarterly earnings first before taking big bets on the cryptocurrency exchange. We also covered the Coinbase figures from their S-1 filing in this recent crypto analysis. In combination with the Coinbase IPO we will add it to our Crypto & Blockchain theme basket which we have done, but not yet published, and then officially launch this basket late this week.

Microsoft in talks to acquire Nuance Communications

The big news in mergers & acquisitions over the weekend was that Microsoft is rumoured to be in talks to acquire the speech recognition company Nuance Communications which has a large presence in the health care sector. The acquisition is rumoured to be set at $56 per share valuing the company at around $16bn and offering existing shareholders a premium of 23% over Friday’s close. The acquisition makes sense as speech recognition technology arguably is going to be key in the future of digitalisation and robotics technology and Microsoft could leverage its commercial distribution to help Nuance to get wider adoption. It is also obvious that Microsoft has many synergies of this technology across their other businesses. Nuance’s stock price has been rallying 212% from the lows in 2020 which looks odd given the sideways pattern over the past 13 years.

Source: Saxo Group

The acquisition is also not given, and we think it could become a key test of antitrust regulation in the US. While the acquisition seems small and innocent it does catapult Microsoft into the health care sector business, and it allows Microsoft to gobble up key technology. With the increased focus on these major technology companies regulators might request Microsoft to insure that it will not limit competition.

Alibaba is fined $2.8bn in antitrust investigation

The continuing saga of Chinese technology regulation took another turn over the weekend with Alibaba being fined $2.8bn because of the recent antitrust investigation. The fine is just above 10% of the company’s free cash flow in a single year and thus does not pose a big problem longer term for Alibaba and the share price also rose in Hong Kong trading as regulators closed the investigation with the fine and said that they like Alibaba and its impact on China. Sentiment on Alibaba shares might improve over the near term, but the longer-term concern is still around the policy objective of more competition by limiting the power of Chinese technology companies over the consumer and to what degree it will impact long-term earnings growth. We have no firm estimate on the impact and we will have to update our view quarter by quarter as we see how regulation impacts the technology sector.

Source: Saxo Group
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.